Shahryar Khoshtinat Nikkhoi

Rutgers, The State University of New Jersey

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 8 papers. Top paper: “Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies”.

Modeling and addressing on-target/off-tumor toxicity of claudin 18.2 targeted immunotherapies

Nature Communications(2025)10.1038/s41467-025-65148-6

N/A

0.472DataRank · unranked

15 citations

Keiko Takahashi, Naoya Sakamoto, Martina De Vizio, Micaela Morgado, Shahryar Khoshtinat Nikkhoi +17 more

Bispecific killer cell engager with high affinity and specificity toward CD16a on NK cells for cancer immunotherapy

Frontiers in Immunology(2023)10.3389/fimmu.2022.1039969

N/A

0DataRank · unranked

47 citations

Geng Li, Suha Eleya, Ge Yang, Venu Gopal Vandavasi, Arash Hatefi +1 more

A high affinity and specificity anti-HER2 single-domain antibody (VHH) that targets trastuzumab’s epitope with versatile biochemical, biological, and medical applications

Immunologic Research(2023)10.1007/s12026-023-09418-9

N/A

0DataRank · unranked

10 citations

Hediyeh Heydarzadeh, Venu Gopal Vandavasi, Ge Yang, Pedro Louro, Marianne Polunas +3 more

Stem cell-assisted enzyme/prodrug therapy makes drug-resistant ovarian cancer cells vulnerable to natural killer cells through upregulation of NKG2D ligands

Medical Oncology(2023)10.1007/s12032-023-01975-1

N/A

0DataRank · unranked

7 citations

Shahryar Khoshtinat Nikkhoi, Arash Hatefi, Geng Li

Gadolinium-labeled affibody-XTEN recombinant vector for detection of HER2+ lesions of ovarian cancer lung metastasis using quantitative MRI

Journal of Controlled Release(2021)10.1016/j.jconrel.2021.07.022

N/A

0DataRank · unranked

15 citations

Geng Li, Siavash Yousefi, Shawn Wu, Obeid M. Malekshah, Shahryar Khoshtinat Nikkhoi +4 more

A Novel Tetravalent Bispecific Immune Cell Engager Activates Natural Killer Cells to Kill Cancer Cells without Mediating Fratricide

Antibodies(2024)10.3390/antib13030075

N/A

0DataRank · unranked

2 citations

Shahryar Khoshtinat Nikkhoi, Hajar Owji, Geng Li, Mohammad Massumi, Jessica A. Cervelli +3 more

Natural killer cell engagers for cancer immunotherapy

Frontiers in Oncology(2025)10.3389/fonc.2024.1483884

N/A

0DataRank · unranked

18 citations

Geng Li, Arash Hatefi, Shahryar Khoshtinat Nikkhoi

Bispecific immune cell engager enhances the anticancer activity of CD16+ NK cells and macrophages in vitro, and eliminates cancer metastasis in NK humanized NOG mice

Journal for ImmunoTherapy of Cancer(2024)10.1136/jitc-2023-008295

N/A

0DataRank · unranked

22 citations

Ge Yang, Hajar Owji, Mayara Grizotte-Lake, Rick I. Cohen, Lázaro Gil +3 more